Should I buy, hold, or sell EMR stock right now?

Emerson Electric Company (EMR) currently earns a Roarable Rating of C+ (Hold — HOLD) with 67/100 RQD Confidence. Solid 52.8% gross margin (10% return on capital), mixed timing at 42x P/E—hold if owned, no rush to chase.

What is EMR's 12-month price target and RQD AI Jury consensus?

EMR's 12-month base price target is $172.68 (range $134.69 to $203.76), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Stock Ratings / Technology / EMR

GEV (46) OTIS (65) GE (56) FXHO (27) ⌘ Pro Terminal →

Emerson Electric Company (EMR) — RQD Stock Rating Cockpit

$165.96 +0.62% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $165.83

Emerson Electric Company (EMR) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $92.00B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on EMR Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is EMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Emerson Electric Company (NYSE: EMR) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 67/100 at a spot price of $165.96 (+0.62% 1D, market cap $92.00B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 11/20. Across 715 tracked Technology issuers, EMR ranks #113 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does EMR compare to GEV and OTIS in the Technology sector?

▼

Within the Technology sector (Consumer Electronics/Appliances), EMR carries a Roarable C+ (67/100 RQD), trailing P/E of 41.5x, gross margin of 52.8%, and ROIC of 9.7%. By comparison, GEV (GE Vernova Inc.) holds a D grade (46/100 RQD, P/E 48.1x, ROIC 4.4%, cap $227.06B) and OTIS (Otis Worldwide Corporation) posts a C grade (65/100 RQD, P/E 20.5x, ROIC 74.2%, cap $28.84B). Among the 5-stock peer group, OTIS leads on earnings multiple (20.5x) while OTIS leads on capital efficiency (74.2% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for EMR?

▼

Per EMR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0000032604), Emerson Electric Company generated $18.02B in revenue (+3.0% YoY), $2.29B in net income, and $2.67B in free cash flow against $41.94B in total assets and $7.58B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $165.83 (-0.08%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 14.8% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 67/100 (C+) historically posted market-perform odds over rolling 90-day windows (+1.6% avg 90D alpha vs SPY • 56.4% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for EMR)Realized 20D OHLCV Swing Band: ±5.7%

Deterministic 5-Pillar Attribution (67/100 Composite)

🔍 WHY EMR SCORES 67/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (27% of score)

Altman Z-Score 4.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Whale & Options Positioning+16/20 pts (24% of score)

20D Institutional Volume Accumulation (±5.7% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit10/20 pts (-10 pt drag)

Macro rate sensitivity & RSI-14 (53.3) create a -10 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$161.08+1.3% Next Q

Q2 (-2Q)

Grade C+$163.11+2.8% Next Q

Q3 (-1Q)

Grade C+$167.71-1% Next Q

Current

Grade C+$165.96+1.6% Hist 90D α

Trajectory: C (59) → C+ (67)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the EMR Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 67/100 (C+) score, EMR faces multiple-compression risk if 41.5x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($157.80) or 200D SMA ($147.35) invalidates the momentum regime and cuts Target Base ($172.68) toward Bear Floor ($134.69).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $EMR• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “EMR Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 67%NO 33%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

53.330 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

4.80>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

7 / 99-Pt Accounting

52-WEEK LASER RANGE89% OF RANGE

L: $123$165.96H: $171

1. Money & Cash Health● MIXED

Are profits real cash in the bank?

Decent core business (52.8% gross margin), though cash flow growth is moderate rather than explosive right now.

Factor Grade: C-RQD 12 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: C+RQD 27 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B-RQD 28 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on EMR

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

NEUTRAL (60)

9.7% ROIC with 52.8% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (90)

Altman-Z 4.80 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (62)

27/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like EMR

✓Big institutional funds and options desks are actively positioning on the bullish side.
✓Clean SEC annual filing review with no major hidden accounting time-bombs.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Priced at 42x earnings—high expectations leave less room for a lukewarm quarter.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (EMR Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

EMR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +22.52%▲ ASCENDING CHANNEL

2026-11-03O $170.7H $170.7L $164.9C $166.0VOL 4.08M

RES: $171.6SUP: $153.2SMA50: $157.8SMA200: $147.4

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

EMR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 EMR Butterfly Map → + Track EMR →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

31.4%/yr Implied 5Y Growth

vs. +3.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on EMR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for EMR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for EMR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EMR)

Technology Rank #113 of 715 ⚔️ GEV vs EMR Full Matrix →

1. Head-to-Head Technology Peer Comparison (EMR vs. GEV, OTIS, GE, FXHO)

Industry: Consumer Electronics/Appliances (22 Tracked Issuers)

Across 715 tracked Technology securities in the Roarable RQD universe, Emerson Electric Company (EMR) ranks #113 by composite RQD confidence (67/100, grade C+) and #45 by equity capitalization ($92.00B). Within this direct 5-issuer industry benchmark cohort, OTIS leads on earnings valuation at 20.5x trailing P/E, while OTIS leads on capital efficiency and profitability with 74.2% ROIC and — gross margin. EMR currently leads its immediate peer cohort in composite quantitative strength at 67/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
EMR ACTIVE Emerson Electric Company	C+	67/100	41.5x	52.8%	9.7%	+0.62%	$92.00B	Benchmark Subject
GEV GE Vernova Inc.	D	46/100	48.1x	19.8%	4.4%	+0.51%	$227.06B	/gev-vs-emr →
OTIS Otis Worldwide Corporation	C	65/100	20.5x	—	74.2%	+3.46%	$28.84B	/otis-vs-emr →
GE GE Aerospace	D+	56/100	37.2x	—	16.8%	+4.63%	$311.87B	/ge-vs-emr →
FXHO UTime Limited (Class A)	E	27/100	—	1.0%	—	-3.64%	$163.2M	/fxho-vs-emr →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-09-30 • CIK 0000032604 ↗

In its most recent audited fiscal period (FY2025, filed 2025-09-30), Emerson Electric Company (EMR) reported GAAP revenue of $18.02B (+3.0% vs. FY2024 revenue of $17.49B , and +18.8% cumulative change since FY2023) , GAAP net income of $2.29B, operating cash flow of $3.10B, and free cash flow of $2.67B (-8.4% YoY). On the balance sheet, EMR closed FY2025 with $41.94B in total assets against $7.58B in total debt (Altman Z-Score: 4.80, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-09-30	$18.02B	$2.29B	$3.10B	$2.67B	$41.94B	$7.58B
FY2024 (FY)	2024-09-30	$17.49B	$1.97B	$3.33B	$2.91B	$42.61B	$6.56B
FY2023 (FY)	2023-09-30	$15.16B	$13.22B	$637.0M	-$45.4M	$52.38B	$12.26B

3. EMR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is EMR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does EMR compare to GEV and OTIS in the Technology sector?

What are the biggest fundamental strengths and SEC risk factors for EMR?

Where is EMR trading relative to its 50-day, 200-day, and 52-week technical levels?

EMR last traded at $165.96 (+0.62% on volume of 3,070,676 shares), positioning the stock +5.17% above its 50-day simple moving average ($157.80) and +12.63% above its 200-day simple moving average ($147.35). Across its 52-week range of $122.64 to $171.25, EMR sits at the 89.1% percentile with a 14-day RSI of 53.3 (NEUTRAL RANGE) and an implied next-earnings move of ±5.7% ($156.50 to $175.42).

Direct Sub-Reports: EMR RQD Cockpit EMR 12M Forecast EMR Earnings & Move EMR Dividends & DRIP EMR Insiders & 13F EMR Whale Options EMR Profit Sankey EMR News & Why

ROARABLE RATING BRIEF • RQD 67/100 (C+) ✓ SEC XBRL & RQD VERIFIED

EMR — Emerson Electric Company: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-09-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Emerson Electric Company (EMR) earns a live Roarable RQD composite score of 67/100, corresponding to a C+ letter grade (Roarable Hold) at a spot price of $165.96 (+0.62% 1D, market capitalization $92.00B).

Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of 9.7%, gross margin of 52.8%, operating margin of 15.5%, and free cash flow yield of 2.80%.
Whale 13F & Options Flow (16/20) + Insider Conviction (11/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (10/20) + Forensic Balance Sheet (18/20): Incorporates a 1.34x equity beta, Altman Z-Score of 4.80, Piotroski F-Score of 7/9, and Debt/Equity of 0.37x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Is a NYSE-listed issuer in the Technology sector, operating in the Consumer Electronics/Appliances industry, with a market capitalization of $95.2B. Per the market data, the company reports a gross margin of 52.8%, an operating margin of 15.5%, and a net margin of 12.7%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-09-30), Emerson Electric Company (EMR) reported $18.02B in annual revenue (up from $17.49B in FY2024, +3.0% YoY) and $2.29B in GAAP net income. Over the multi-year SEC filing window from FY2023 ($15.16B revenue, $13.22B net income) through FY2025, EMR scaled operating cash flow to $3.10B and free cash flow to $2.67B, backed by $41.94B in total assets against $7.58B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (C+ • RQD 67/100): Big institutional funds and options desks are actively positioning on the bullish side. Clean SEC annual filing review with no major hidden accounting time-bombs. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 16/20, sustained execution supports upside toward the upper end of the $122.64 – $171.25 52-week range.
🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 41.5x trailing P/E and 30.9x EV/EBITDA against 15.5% operating margins and a 1.34x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Consumer Electronics/Appliances (Technology), EMR carries a macro regime beta of 1.34 and gross margin of 52.8%.

Key Question #1: Can EMR sustain or expand its 15.5% operating margin and 9.7% ROIC against Consumer Electronics/Appliances peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $18.02B and free cash flow of $2.67B, how will capital allocation balance growth reinvestment against $7.58B in total debt?
Key Question #3: How sensitive is EMR's 38.6x forward P/E multiple to Technology capital spending cycles and macro interest-rate shifts (Beta 1.34x)?

EMR Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Emerson Electric Company (EMR) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to EMR Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 23h ago

Emerson Electric Company (EMR) Stock Forecasts

Yahoo Finance report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE 24/7 Wall St. • 1d ago

Emerson Electric (EMR) Stock Price, News & Analysis

24/7 Wall St. report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

Emerson Electric Company Estimates – NYSE:EMR

TradingView report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 1d ago

Sawyer & Company Inc Makes New $2.90 Million Investment in Emerson Electric Co. $EMR

MarketBeat report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 1d ago

33,800 Emerson Electric Co. $EMR Shares Sold by Willis Investment Counsel

MarketBeat report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Kalkine Media • 1d ago

Is Emerson Electric (NYSE:EMR) Expanding Its Industrial Market Reach?

Kalkine Media report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 1d ago

Emerson Electric Co. (NYSE:EMR) Stock Has Consensus Target Price of $171.00 According to Analysts

MarketBeat report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Kalkine Media • 1d ago

Is Emerson Electric (NYSE:EMR) Software Strength Setting Up A Strong Finish?

Kalkine Media report covering Emerson Electric Company (EMR) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

EMR Bull vs. Bear Conversation Board — What's Your Call at $165.96?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON EMR 🐻 33% BEARISH CONVICTION

MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH 🎯 Target: $212.77 (+29.0%)

📌 Pinned Debate

Institutional whale flow (18/20) and a strong forensic balance sheet (Altman Z 4.8, Piotroski F 7/9) support the rating.

The street is overcomplicating Emerson Electric Company (EMR). Institutional whale flow (18/20) and a strong forensic balance sheet (Altman Z 4.8, Piotroski F 7/9) support the rating.. With an RQD score of 67/100 (C+) and Forensic Balance Sheet at 18/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $178.14.

ArenaChamp_24 🐂 BULL

@MidwestValue Agree on the RQD 67/100 quality, though with 1.34 beta I'm scaling in with half-size at $164.94 and keeping dry powder in case we test $153.39.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $138.55 (-16.0%)

Spot @ $164.94

Elevated valuation (P/E TTM 41.5, EV/EBITDA 30.9) against a 2.8% FCF yield and Beta of 1.34 limits the upside case.

Sitting on the sidelines or leaning short EMR above $164.94. Elevated valuation (P/E TTM 41.5, EV/EBITDA 30.9) against a 2.8% FCF yield and Beta of 1.34 limits the upside case.. Until Fundamental Cash Engine (12/20) and FCF yield (2.8%) inflect higher, upside is capped near $171.25.